DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Pfeifer H, Wassmann B, Bethge W. et al.
GMALL Study Group. Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia.
Leukemia 2013;
27 (06) 1254-1262
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.